Serniak Iu P
Urol Nefrol (Mosk). 1998 Jan-Feb(1):32-5.
Basing on the long-term results of nephrectomy in 180 patients with renal cell carcinoma, the detailed assessment has been made of implications of a number of factors in 5-year survival and contribution of these factors to the disease outcome. The author proposes a method of prognosticating the disease outcome in patients with localized and locally advanced renal carcinoma which enables specification of the existing international classification and more precise prognosis of the disease. At stages T2, T3 and T4, 5-year survival reached in the subgroups with good prognosis 74.1, 100, and 30.8% of patients, respectively; with poor prognosis 7.1, 5.3, and 0%, respectively. Prognostic subgroup of the patient should be considered in the design of the treatment scheme.
基于180例肾细胞癌患者肾切除术的长期结果,对若干因素对5年生存率的影响以及这些因素对疾病结局的作用进行了详细评估。作者提出了一种预测局限性和局部进展性肾癌患者疾病结局的方法,该方法能够细化现有的国际分类并更精确地预测疾病。在T2、T3和T4期,预后良好的亚组患者5年生存率分别达到74.1%、100%和30.8%;预后不良的亚组分别为7.1%、5.3%和0%。在设计治疗方案时应考虑患者的预后亚组。